Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2017: 3.022

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 384, Issue 3

Issues

Evidence for Coordinated Induction and Repression of Ecto-5'-Nucleotidase (CD73) and the A2a Adenosine Receptor in a Human B Cell Line

R. Napieralski / B. Kempkes / W. Gutensohn
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2003.054

Abstract

In the human B cell line P493-6 two mitogenic signals, the Epstein-Barr virus nuclear antigen 2 (EBNA2) and myc, can be independently regulated by means of an estrogen receptor fusion construct or an inducible expression vector, respectively. Shut off of EBNA2, either in the presence or absence of myc, leads to a significant increase in enzymatic activity and surface expression of ecto-5'nucleotidase (CD73) as well as an increased adenosine receptor response in cyclic AMP formation. Shut off of myc expression has a small additional positive effect on CD73 activity. Among the four different subtypes of adenosine receptors, the A2a receptor exclusively is subject to regulation in this system, which is substantiated by pharmacologic data (specific agonists and inhibitors), as well as on the mRNA level. With upregulated CD73 and A2a, cells also respond to 5'-AMP with increased cyclic AMP formation. Turn on of EBNA2 has the reverse effect of repression of CD73 and A2a expression. The time course of both induction and repression of CD73 and A2a is rather slow.

About the article

Published Online: 2005-06-01

Published in Print: 2003-03-14


Citation Information: Biological Chemistry, Volume 384, Issue 3, Pages 483–487, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2003.054.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Shanmugam Muruganandan, Rajgopal Govindarajan, and Christopher J. Sinal
Current Osteoporosis Reports, 2018
[2]
Jonathan M. Bekisz, Christopher D. Lopez, Carmen Corciulo, Aranzazu Mediero, Paulo G. Coelho, Lukasz Witek, Roberto L. Flores, and Bruce N. Cronstein
Inflammation, 2018
[5]
Aren van Waarde, Rudi A. J. O. Dierckx, Xiaoyun Zhou, Shivashankar Khanapur, Hideo Tsukada, Kiichi Ishiwata, Gert Luurtsema, Erik F. J. de Vries, and Philip H. Elsinga
Medicinal Research Reviews, 2017
[6]
Bruce N. Cronstein and Michail Sitkovsky
Nature Reviews Rheumatology, 2016, Volume 13, Number 1, Page 41
[7]
Aurora R. Barros-Barbosa, Fátima Ferreirinha, Ângela Oliveira, Marina Mendes, M. Graça Lobo, Agostinho Santos, Rui Rangel, Julie Pelletier, Jean Sévigny, J. Miguel Cordeiro, and Paulo Correia-de-Sá
Purinergic Signalling, 2016, Volume 12, Number 4, Page 719
[8]
Rodrigo A. Cunha
Journal of Neurochemistry, 2016, Volume 139, Number 6, Page 1019
[9]
Eveline Dischkaln Stolz, Paola Fontoura da Costa, Liciane Fernandes Medeiros, Andressa Souza, Ana Maria Oliveira Battastini, Gilsane Lino von Poser, Carla Bonan, Iraci L. S. Torres, and Stela Maris Kuze Rates
Evidence-Based Complementary and Alternative Medicine, 2016, Volume 2016, Page 1
[10]
Holger K. Eltzschig, Juan C. Ibla, Glenn T. Furuta, Martin O. Leonard, Kenneth A. Jacobson, Keiichi Enjyoji, Simon C. Robson, and Sean P. Colgan
The Journal of Experimental Medicine, 2003, Volume 198, Number 5, Page 783
[12]
Francesca Schena, Stefano Volpi, Caterina Elisa Faliti, Federica Penco, Spartaco Santi, Michele Proietti, Ursula Schenk, Gianluca Damonte, Annalisa Salis, Marta Bellotti, Franco Fais, Claudya Tenca, Marco Gattorno, Hermann Eibel, Marta Rizzi, Klaus Warnatz, Marco Idzko, Cemil Korcan Ayata, Mirzokhid Rakhmanov, Thierry Galli, Alberto Martini, Marco Canossa, Fabio Grassi, and Elisabetta Traggiai
Cell Reports, 2013, Volume 3, Number 6, Page 1824
[13]
Georg Pongratz and Rainer H. Straub
Brain, Behavior, and Immunity, 2010, Volume 24, Number 2, Page 186
[14]
Holger K. Eltzschig, Christopher F. MacManus, and Sean P. Colgan
Trends in Cardiovascular Medicine, 2008, Volume 18, Number 3, Page 103
[15]
M.J.L. Bours, E.L.R. Swennen, F. Di Virgilio, B.N. Cronstein, and P.C. Dagnelie
Pharmacology & Therapeutics, 2006, Volume 112, Number 2, Page 358
[16]
[17]
Thomas Weissmuller, Holger K. Eltzschig, and Sean P. Colgan
Purinergic Signalling, 2005, Volume 1, Number 3, Page 229
[18]
Monika Sakowicz-Burkiewicz, Katarzyna Kocbuch, Marzena Grden, Andrzej Szutowicz, and Tadeusz Pawelczyk
Journal of Cellular Biochemistry, 2009, Page n/a
[19]
Norbert Sträter
Purinergic Signalling, 2006, Volume 2, Number 2, Page 343
[20]
Sean P. Colgan, Holger K. Eltzschig, Tobias Eckle, and Linda F. Thompson
Purinergic Signalling, 2006, Volume 2, Number 2, Page 351
[22]
Antonio Pinto-Duarte, Joana E. Coelho, Rodrigo A. Cunha, Joaquim Alexandre Ribeiro, and Ana M. Sebastiao
Journal of Neurochemistry, 2005, Volume 93, Number 3, Page 595

Comments (0)

Please log in or register to comment.
Log in